作者: Simon P. F. Lambden , Charlotte Summers
DOI: 10.1007/978-3-030-31507-8_13
关键词:
摘要: One of the key challenges in critical care medicine is syndromic nature two most common clinical presentations – sepsis and acute respiratory distress syndrome (ARDS). Understanding biological pathogenic processes underlying these conditions incomplete, there has been limited success developing biomarkers that conform to NIH definition a biomarker as ‘a characteristic objectively measured evaluated an indicator normal processes, or pharmacologic responses therapeutic intervention’. In this chapter we provide overview various ways which have used ARDS review steps are needed make progress towards taking precision bedside critically ill patients.